Skip to content

Supplemental Anterior Lumbar Interbody Fusion (ALIF) in Spinal Deformity

Supplemental Anterior Lumbar Interbody Fusion in Posterior Instrumented Fusion in Surgical Treatment of Spinal Deformities. A Randomized Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01601054
Acronym
SALIF
Enrollment
30
Registered
2012-05-17
Start date
2012-05-31
Completion date
2015-12-31
Last updated
2016-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Deformity

Keywords

spine, deformity, instrumentation, ALIF

Brief summary

Within the last decade there has been an increase in the number of surgical procedures for deformities of the spine. This is caused by the increase in the elderly population, improved surgical techniques and an increased number of patients who have undergone previous surgical treatment for degenerative conditions of the spine. Surgical treatment of spinal deformities bears a revision rate between 15 and 30% depending on definition, and one of the primary reasons for revision surgery is implant loosening in the lumbosacral region. The hypothesis of the study is that a procedure resulting in anterior fusion of the lumbar spine in addition to the usual posterior instrumentation can reduce the revision rate with 50%.

Interventions

DEVICETantalum cage from Zimmer

A tantalum cage will be inserted through a left sided retroperitoneal approach

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or more of age * planned posterior instrumented fusion from thoracic spine to sacrum and/or ilium

Exclusion criteria

* malignancy * infection

Design outcomes

Primary

MeasureTime frameDescription
Revision12 monthsSurgical revision rate because of implant failure or pseudarthrosis within 12 months after primary procedure

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026